MEDIPOST Co., Ltd.
PublicMEDIPOST Co., Ltd. is now publicly traded
The data on this page reflects MEDIPOST Co., Ltd.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Early Funding
Jan 9, 2026
Total Funding Raised
$140M
Company Overview
MEDIPOST Co., Ltd. is a biotechnology company that develops and commercializes allogeneic, umbilical cord blood-derived stem cell therapies for inflammation-driven and degenerative diseases.
AI Layer
Non-AI
Keywords
MEDIPOST Co., Ltd. Comparables
Compare MEDIPOST Co., Ltd. with similar companies based on industry and business-model similarity.
No public comparables are available for MEDIPOST Co., Ltd.. Request access to learn about comparables coverage.
Request accessMEDIPOST Co., Ltd. Funding Rounds
Historical fundraising activity
MEDIPOST Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Crescendo Equity Partners | Early Funding |
MEDIPOST Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access